Skip to main content

Table 6 Cognitive performance and side effects of systemic treatment in relation to surgery type, based on QLQ-C30 and QLQ-BR23 questionnaire results

From: Quality of life during chemotherapy, hormonotherapy or antiHER2 therapy of patients with advanced, metastatic breast cancer in clinical practice

QLQ-C30

Type of therapy

Average

Standard deviation

Median

U Manna–Whitney test

Performance scales*

 Cognitive performance

chemotherapy

64,45

23,11

63,67

p = 0,031

Hormone therapy

81,16

21,82

83,67

QLQ-BR-23

Type of therapy

Average

Standard deviation

Median

U Manna–Whitney test

Symptom scales**

 Side effects of systemic treatment

chemotherapy

58,97

11,73

59,00

p = 0,003

Hormone therapy

28,33

16,11

29,34